Kyntra Bio (1FG0) Ownership - Who Owns Kyntra Bio?
Kyntra Bio (1FG0) Ownership Overview
- 3.37% Insiders
- 22.63% Mutual Funds
- 0.01% Other Institutional Investors
- 3.86% ETFs
- 70.13% Public Companies and Individual Investors
The ownership structure of Kyntra Bio (DE:1FG0) stock is a mix of institutional, retail, and individual investors. Approximately 26.51% of the company’s stock is owned by Institutional Investors, 3.37% is owned by Insiders, and 70.13% is owned by Public Companies and Individual Investors.
The ownership structure of Kyntra Bio (DE:1FG0) stock is a mix of institutional, retail, and individual investors. Approximately 26.51% of the company’s stock is owned by Institutional Investors, 3.37% is owned by Insiders, and 70.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 17, 2026 | Thane Wettig | $19,852 | |
| Nov 16, 2025 | Thane Wettig | $33,723 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| T. Rowe Price Quantitative Management Funds, Inc. | 421,400 | Institution | 10.41% | 1,835,197 |
| Fidelity Commonwealth Trust Ii | 169,479 | Institution | 4.19% | 738,081 |
| Vanguard | 156,444 | Institution | 3.86% | 681,314 |
| Vanguard Index Funds | 156,444 | Institution | 3.86% | 681,314 |
| BlackRock, Inc. | 84,330 | Institution | 2.08% | 367,257 |
| Tiaa-cref Funds | 83,092 | Institution | 2.05% | 361,866 |
| James Schoeneck | 39,666 | Insider | 0.98% | 172,745 |
| Northern Funds | 37,111 | Institution | 0.92% | 161,618 |
| Jeffrey L. Edwards | 33,977 | Insider | 0.84% | 147,970 |
| Fidelity Concord Street Trust | 33,660 | Institution | 0.83% | 146,589 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| T. Rowe Price Quantitative Management Funds, Inc. | 421,400 | Institution | 10.41% | 1,835,197 |
| Fidelity Commonwealth Trust Ii | 169,479 | Institution | 4.19% | 738,081 |
| Vanguard Index Funds | 156,444 | Institution | 3.86% | 681,314 |
| Tiaa-cref Funds | 83,092 | Institution | 2.05% | 361,866 |
| Northern Funds | 37,111 | Institution | 0.92% | 161,618 |
| Fidelity Concord Street Trust | 33,660 | Institution | 0.83% | 146,589 |
| Victory Portfolios Iii | 9,685 | Institution | 0.24% | 42,178 |
| Vanguard Valley Forge Funds | 3,506 | Institution | 0.09% | 15,269 |
| Vanguard Horizon Funds | 2,716 | Institution | 0.07% | 11,828 |
| Advisors' Inner Circle Iii | 20 | Institution | <0.01% | 87 |
FAQ
Who Owns Kyntra Bio (DE:1FG0)?
According to the latest TipRanks data, approximately 26.51% of the company's stock is held by institutional investors, 3.37% is held by insiders, and 70.13% is held by public companies and individual investors.
What percentage of Kyntra Bio (DE:1FG0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.51% of Kyntra Bio (DE:1FG0) stock is held by institutional investors: 22.63% by mutual funds, 3.86% by ETFs and 0.01% by other institutional investors.
What percentage of Kyntra Bio (DE:1FG0) stock is held by retail investors?
According to the latest TipRanks data, approximately 70.13% of Kyntra Bio (DE:1FG0) stock is held by public companies and individual investors.
Who owns the most shares of Kyntra Bio (DE:1FG0)?
T. ROWE PRICE QUANTITATIVE MANAGEMENT FUNDS, INC. owns the most shares of Kyntra Bio (DE:1FG0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
